Journal rankings · indicator year 2011
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2011
Cancer Research journal rankings 2011
20 ranked journals · Subfield in Biochemistry, Genetics and Molecular Biology
Cancer Research has 20 ranked journals in 2011. The median OJR rose 0.08 on 2010 to 0.80, below the world average of 1.00; Q1 starts at OJR 1.32. The top three are Mutation Research/Reviews in Mutation Research, Critical Reviews in Eukaryotic Gene Expression, and Journal of Molecular Diagnostics.
Ranks and citation indicators: 2011. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2008–2010, the window the 2011 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Biochemistry, Genetics and Molecular Biology (14)
20 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2010. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2008–2010, the window the 2011 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2008–2010 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2002 to 2011. | Compare |
|---|---|---|---|---|---|---|---|
1Mutation Research/Reviews in Mutation ResearchElsevier BV · Netherlands | 3.39Q1 | 7.25 2.97 down from 2010 | 114 | 28% | $4,160 | ||
2Critical Reviews in Eukaryotic Gene ExpressionBegell House · United States | 2.02Q1 | 4.85 1.01 down from 2010 | 58 | 21% | — | ||
3Journal of Molecular DiagnosticsElsevier BV · United States | 1.98Q1 | 4.50 0.27 up from 2010 | 261 | 100% | $3,000 | ||
4Environmental and Molecular MutagenesisWiley · United States | 1.37Q1 | 3.69 0.47 up from 2010 | 277 | 12% | $3,750 | ||
5Journal of Molecular SignalingOABioMed Central · United Kingdom | 1.32Q1 | 3.54 0.36 up from 2010 | 48 | 100% | — | ||
6Breast Cancer Research and TreatmentSpringer Science+Business Media · Netherlands | 1.30Q2 | 4.45 0.09 up from 2010 | 1,392 | 34% | $4,190 | ||
7Mutation Research/Genetic Toxicology and Environmental MutagenesisElsevier BV · Netherlands | 1.22Q2 | 3.00 0.52 down from 2010 | 513 | 11% | $3,350 | ||
8Clinical Breast CancerElsevier BV · United States | 1.20Q2 | 3.31 0.49 down from 2010 | 208 | 25% | $3,470 | ||
9MutagenesisOxford University Press · United Kingdom | 1.14Q2 | 3.49 0.93 down from 2010 | 249 | 47% | $4,170 | ||
10Biomarker InsightsOASAGE Publishing · United Kingdom | 0.83Q2 | 3.31 1.97 up from 2010 | 76 | 100% | $2,650 | ||
11The BreastOAElsevier BV · United Kingdom | 0.77Q3 | 2.26 0.26 up from 2010 | 366 | 100% | $3,200 | ||
12Pathology - Research and PracticeElsevier BV · Germany | 0.73Q3 | 1.57 0.15 up from 2010 | 415 | 6% | $2,780 | ||
13The Breast JournalOAWiley · United Kingdom | 0.69Q3 | 1.84 0.15 up from 2010 | 402 | 58% | $2,350 | ||
14Breast CancerSpringer Science+Business Media · Japan | 0.62Q3 | 1.63 0.09 down from 2010 | 212 | 13% | $3,890 | ||
15British Journal of Biomedical ScienceOATaylor & Francis · United Kingdom | 0.54Q3 | 1.24 0.36 up from 2010 | 75 | 4% | $2,506 | ||
16Breast DiseaseIOS Press · Netherlands | 0.47Q4 | 0.82 0.81 down from 2010 | 30 | 38% | — | ||
17Breast Diseases A Year Book QuarterlyElsevier BV · Netherlands | 0.18Q4 | 0.54 0.19 up from 2010 | 684 | 0% | — | ||
18Genes and EnvironmentOABioMed Central · Japan | 0.13Q4 | 0.33 0.33 down from 2010 | 55 | 100% | $2,590 | ||
19Journal of Breast CancerOASouth Korea | 0.10Q4 | 0.44 0.01 up from 2010 | 151 | 100% | $500 | ||
20International Journal of Human GeneticsOAKamla Raj Enterprises · India | 0.09Q4 | 0.37 0.18 up from 2010 | 181 | 5% | — |
Subfields of Biochemistry, Genetics and Molecular Biology, with Cancer Research highlighted.
- Molecular Biology901
- Genetics99
- Cell Biology21
- Cancer Research20
- Molecular Medicine7
- Biophysics6
- Biochemistry3
- Clinical Biochemistry2
- Structural Biology2
- Developmental Biology1
- Endocrinology1
- Physiology1
- Aging0
- Biotechnology0
Journals
Citations made in 2011. Corpus-wide, 75.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
10 additional Cancer Research journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2008–2010, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2011. Publication window: 2008–2010. How these summaries are calculated
- Ranked journals
- 20
- Window papers (baseline)
- 35,940 +30.5% from indicator year 2008
- Median OJR
- 0.798 +3.9% from indicator year 2008
- Rising journals (2025)
- 2
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2008–2010 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 12 | 14 | 15 | 16 | 16 | 19 | 20 | 21 | 21 | 22 | 21 | 20 | 21 | 24 | 23 | 25 | 26 | 27 | 28 | 27 | 29 | 27 | 27 | 26 | 27 | 29 | |
| Window papers (baseline) | 14,247 | 15,312 | 16,615 | 17,745 | 18,774 | 20,529 | 22,718 | 25,259 | 27,535 | 30,135 | 32,914 | 35,940 | 38,839 | 41,424 | 44,722 | 47,640 | 50,019 | 51,182 | 52,328 | 54,530 | 57,576 | 61,698 | 64,508 | 64,646 | 60,806 | 56,699 | |
| Median OJR | 0.49 | 0.50 | 0.46 | 0.60 | 0.71 | 0.58 | 0.67 | 0.680 | 0.768 | 0.8139 | 0.72 | 0.798 | 0.93 | 0.92 | 0.88 | 0.84 | 0.7969 | 0.8143 | 0.804 | 0.82 | 0.76 | 0.679 | 0.70 | 0.79 | 0.770 | 0.7966 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.